首页> 外文OA文献 >Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities
【2h】

Synthesis of Amide and Ester Derivatives of Cinnamic Acid and Its Analogs: Evaluation of Their Free Radical Scavenging and Monoamine Oxidase and Cholinesterase Inhibitory Activities

机译:肉桂酸及其衍生物的酰胺和酯衍生物的合成:其自由基清除和单胺氧化酶和胆碱酯酶抑制活性的评价

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of cinnamic acid derivatives, amides (1–12) and esters (13–22), were synthesized, and structure–activity relationships for antioxidant activity, and monoamine oxidases (MAO) A and B, acetylcholinesterase, and butyrylcholinesterase (BChE) inhibitory activities were analyzed. Among the synthesized compounds, compounds 1–10, 12–18, and rosmarinic acid (23), which contained catechol, o-methoxyphenol or 5-hydroxyindole moieties, showed potent 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical scavenging activity. Compounds 9–11, 15, 17–22 showed potent and selective MAO-B inhibitory activity. Compound 20 was the most potent inhibitor of MAO-B. Compounds 18 and 21 showed moderate BChE inhibitory activity. In addition, compound 18 showed potent antioxidant activity and MAO-B inhibitory activity. In a comparison of the cinnamic acid amides and esters, the amides exhibited more potent DPPH free radical scavenging activity, while the esters showed stronger inhibitory activities against MAO-B and BChE. These results suggested that cinnamic acid derivatives such as compound 18, p-coumaric acid 3,4-dihydroxyphenethyl ester, and compound 20, p-coumaric acid phenethyl ester, may serve as lead compounds for the development of novel MAO-B inhibitors and candidate lead compounds for the prevention or treatment of Alzheimer’s disease.
机译:合成了一系列肉桂酸衍生物,酰胺(1–12)和酯(13–22),并建立了抗氧化活性与单胺氧化酶(MAO)A和B,乙酰胆碱酯酶和丁酰胆碱酯酶(BChE)的结构-活性关系。分析抑制活性。在合成的化合物中,化合物1-10、12-18和迷迭香酸(23)含有邻苯二酚,邻甲氧基苯酚或5-羟基吲哚部分,它们显示出有效的1,1-二苯基-2-吡啶并肼基(DPPH)自由基清除活动。化合物9-11、15、17-22显示出有效和选择性的MAO-B抑制活性。化合物20是最有效的MAO-B抑制剂。化合物18和21显示出中等的BChE抑制活性。另外,化合物18显示出有效的抗氧化剂活性和MAO-B抑制活性。在肉桂酸酰胺和酯的比较中,酰胺显示出更强的DPPH自由基清除活性,而酯显示出对MAO-B和BChE的较强抑制活性。这些结果表明,肉桂酸衍生物,例如化合物18,对香豆酸3,4-二羟基苯乙基酯,和化合物20,对香豆酸苯乙酯,可以用作开发新型MAO-B抑制剂和候选化合物的先导化合物。预防或治疗阿尔茨海默氏病的先导化合物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号